Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older.

ABSTRACT:

Background

Monitoring safety outcomes following COVID-19 vaccination is critical for understanding vaccine safety especially when used in key populations such as elderly persons age 65 years and older who can benefit greatly from vaccination. We present new findings from a nationally representative early warning system that may expand the safety knowledge base to further public trust and inform decision making on vaccine safety by government agencies, healthcare providers, interested stakeholders, and the public.

Methods

We evaluated 14 outcomes of interest following COVID-19 vaccination using the US Centers for Medicare & Medicaid Services (CMS) data covering 30,712,101 elderly persons. The CMS data from December 11, 2020 through Jan 15, 2022 included 17,411,342 COVID-19 va

SUBMITTER: Wong HL 

PROVIDER: S-EPMC9712075 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature